Glyphic Biotechnologies Glyphic Biotechnologies is a biotechnology company that provides proteomics solutions. | ![]() Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. | ![]() AmacaThera AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications. | ![]() Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. | ||
Founding Date | Founding Date 2021 | Founding Date 2010 | Founding Date 2017 | Founding Date 2016 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Berkeley, US HQ | Locations Ecublens, CH HQ Cambridge, US | Locations New York, US HQ | Locations Toronto, CA HQ Toronto, CA | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US |
Employees | Employees 3310% increase | Employees 219% decrease | Employees 524% decrease | Employees 12 | Employees 75 |
Funding | |||||
Latest funding round | Latest funding round $ 6m (almost 5 years ago) | Latest funding round $ 40m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 3.6m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 6m | Total funding raised $ 77.6m | Total funding raised N/A | Total funding raised $ 6.1m | Total funding raised $ 223.5m |

Anokion is an immune tolerance company focused on autoimmune disease treatment.
View company
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View company
AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications.
View company
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company